BioSpace News Archive

Press Releases

Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results

October 28, 2025
·
1 min read
Press Releases

Coya Therapeutics Announces Closing of $23.0 Million Upsized Public Offering of Common Stock, Including Full Exercise of Underwriter’s Option to Purchase Additional Shares

October 28, 2025
·
4 min read
Press Releases

CORRECTING and REPLACING Faeth Therapeutics’ $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer

October 28, 2025
·
5 min read
Press Releases

Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28

October 28, 2025
·
4 min read
Press Releases

Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX® Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care

October 28, 2025
·
4 min read
Press Releases

Successful Patient Outcomes Demonstrated With Edwards’ SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025

October 28, 2025
·
4 min read
Press Releases

BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update

October 28, 2025
·
25 min read
Press Releases

Lilly’s Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis

October 28, 2025
·
12 min read
Press Releases

Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025

October 28, 2025
·
5 min read
Press Releases

Aurora Spine Launches New Biologics Portfolio

October 28, 2025
·
4 min read